Shenzhen Bioeasy Biotechnology Co., Ltd.
SZSE:300942.SZ
11.43 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 481.749 | 247.451 | 342.211 | 379.097 | 442.27 | 189.343 | 99.492 | 69.223 |
| Short Term Investments
| 120.028 | -14.304 | 340.213 | -20.089 | -6.442 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 601.777 | 247.451 | 682.424 | 379.097 | 442.27 | 189.343 | 99.492 | 69.223 |
| Net Receivables
| 98.462 | 84.028 | 97.37 | 64.019 | 74.959 | 46.112 | 25.412 | 15.706 |
| Inventory
| 31.461 | 100.608 | 93.859 | 61.59 | 31.338 | 22.289 | 14.394 | 9.676 |
| Other Current Assets
| 104.433 | 227.159 | 23.991 | 30.689 | 30.618 | 12.998 | 13.511 | 9.088 |
| Total Current Assets
| 737.67 | 674.419 | 897.644 | 526.129 | 569.721 | 268.657 | 149.254 | 100.843 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 426.525 | 324.641 | 143.441 | 44.887 | 29.413 | 15.726 | 12.871 | 12.492 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 41.393 | 42.4 | 42.6 | 44.124 | 1.362 | 0.725 | 0.398 | 0.038 |
| Goodwill and Intangible Assets
| 41.393 | 42.4 | 42.6 | 44.124 | 1.362 | 0.725 | 0.398 | 0.038 |
| Long Term Investments
| 25.151 | 210.062 | -318.269 | 23.596 | 10.11 | 3.271 | 4.871 | 1.794 |
| Tax Assets
| 3.056 | 14.903 | 7.4 | 7.34 | 4.672 | 5.49 | 5.333 | 6.024 |
| Other Non-Current Assets
| 122.545 | 16.03 | 379.704 | 6.81 | 4.388 | 2.965 | 1.072 | 1.875 |
| Total Non-Current Assets
| 618.669 | 608.036 | 254.876 | 126.757 | 49.944 | 28.177 | 24.545 | 22.223 |
| Total Assets
| 1,356.339 | 1,282.456 | 1,152.52 | 652.886 | 619.665 | 296.834 | 173.799 | 123.066 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 77.352 | 65.107 | 55.658 | 14.644 | 10.383 | 3.959 | 3.315 | 2.528 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 1.214 | 5.795 | 13.295 | 9.86 | 14.144 | 7.435 | 5.956 | 7.04 |
| Deferred Revenue
| 0 | 108.026 | 84.837 | 36.028 | 29.898 | 18.732 | 8.982 | 0 |
| Other Current Liabilities
| 58.361 | 62.267 | 87.673 | 66.039 | 43.564 | 30.104 | 16.95 | 19.199 |
| Total Current Liabilities
| 136.927 | 199.784 | 156.626 | 78.119 | 68.091 | 41.498 | 26.221 | 28.767 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 351.117 | 95.566 | 27.12 | 41.663 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 16.543 | 20.325 | 22.194 | 25.784 | 23.255 | 32.718 | 32.973 | 39.059 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -22.194 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.024 | 2.08 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 370.684 | 117.971 | 49.314 | 25.784 | 23.255 | 32.718 | 32.973 | 39.059 |
| Total Liabilities
| 507.611 | 317.754 | 205.94 | 103.903 | 91.346 | 74.216 | 59.194 | 67.827 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 400.86 | 400.86 | 400.86 | 360 | 360 | 52.067 | 50.505 | 10 |
| Retained Earnings
| 138.444 | 331.85 | 351.986 | 156.199 | 142.631 | 67.014 | 28.629 | 40.395 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 96.115 | 55.841 | 31.272 | 44.915 | 103.609 | 35.519 | 0 |
| Other Total Stockholders Equity
| 309.69 | 232.276 | 192.201 | 1.582 | -19.152 | 103.609 | 35.519 | 0 |
| Total Shareholders Equity
| 848.994 | 964.891 | 944.763 | 549.054 | 528.394 | 222.69 | 114.653 | 55.26 |
| Total Equity
| 848.728 | 964.701 | 946.58 | 548.983 | 528.32 | 222.617 | 114.605 | 55.24 |
| Total Liabilities & Shareholders Equity
| 1,356.339 | 1,282.456 | 1,152.52 | 652.886 | 619.665 | 296.834 | 173.799 | 123.066 |